These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5022753)

  • 1. [Influence of an estrogenic treatment on the skin of menopausal or castrated women].
    Aertgeerts J
    Brux Med; 1972 Mar; 52(3):215-28. PubMed ID: 5022753
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of oral estrogen treatment with estriol succinate on the skin of castrated women].
    Rauramo L; Punnonen R
    Z Haut Geschlechtskr; 1969 Jul; 44(13):463-70. PubMed ID: 5360189
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of estriol on the castrated of post-menopausal woman].
    Aertgeerts J
    Brux Med; 1975 Apr; 55(4):215-25. PubMed ID: 1222363
    [No Abstract]   [Full Text] [Related]  

  • 4. On the effect of castration and peroral estrogen therapy on the skin.
    Punnonen R
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:32. PubMed ID: 5287103
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of menopausal complants with polyoestriol-phosphate. Experiences with Gynäsan injections].
    Bachmann FF
    Munch Med Wochenschr; 1971 Jan; 113(5):166-9. PubMed ID: 5107471
    [No Abstract]   [Full Text] [Related]  

  • 6. Oestriol succinate in the treatment of climacteric women (a double-blind trial).
    Järvinen PA; Kokkonen J; Ryhänen P
    Acta Obstet Gynecol Scand Suppl; 1971; 9():Suppl 9:26. PubMed ID: 4941231
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of long-term oral oestriol succinate therapy on the skin of castrated women.
    Punnonen R; Rauramo L
    Ann Chir Gynaecol; 1977; 66(4):214-5. PubMed ID: 334028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of progressive systemic sclerosis (PSS) with estriol treatment.
    Katayama H; Ohsawa K; Yaoita H
    Acta Derm Venereol; 1984; 64(2):168-71. PubMed ID: 6203310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of climacteric urogenital disorders with an estriol-containing ointment].
    Koloszár S; Kovács L
    Orv Hetil; 1995 Feb; 136(7):343-5. PubMed ID: 7870416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Colpocytological and urocytological modifications induced by estriol in menopausal women].
    Perretti F
    Minerva Ginecol; 1967 Jun; 19(12):647-52. PubMed ID: 5611226
    [No Abstract]   [Full Text] [Related]  

  • 11. [Estriol therapy of the menopause and in the post-menopausal period].
    Proost J; Demol R; Barbier F; Callaerts J; Huyghebaert G; Hooghe R
    Bull Soc R Belge Gynecol Obstet; 1969; 39(1):65-83. PubMed ID: 5791879
    [No Abstract]   [Full Text] [Related]  

  • 12. [Transvaginal administration of estriol in postmenopausal urogynecological disorders].
    Di Stefano L; Patacchiola F; Moscarini M
    Minerva Ginecol; 1993 Nov; 45(11):551-6. PubMed ID: 8121603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Actions of castration and estrogen treatment in the skin of the woman (author's transl].
    Rauramo L; Punnonen R
    Ther Umsch; 1974 Mar; 31(3):173-5. PubMed ID: 4816754
    [No Abstract]   [Full Text] [Related]  

  • 14. [Menopause and climacteric].
    Usandizaga JA
    Acta Obstet Ginecol Hisp Lusit; 1976 Feb; 24(2):61-98. PubMed ID: 799894
    [No Abstract]   [Full Text] [Related]  

  • 15. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy.
    Trevoux R; van der Velden WH; Popović D
    Reproduccion; 1982; 6(2):101-6. PubMed ID: 7141096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hormonal replacement therapy on skin biophysical properties of menopausal women.
    Guinot C; Malvy D; Ambroisine L; Latreille J; Mauger E; Guéhenneux S; Morizot F; Tschachler E
    Skin Res Technol; 2005 Aug; 11(3):201-4. PubMed ID: 15998332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of estrogen in the treatment of menopausal skin and urogenital diseases].
    Kujansuu E
    Duodecim; 1996; 112(12):1105-8. PubMed ID: 10593012
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects and side-effects of 2% progesterone cream on the skin of peri- and postmenopausal women: results from a double-blind, vehicle-controlled, randomized study.
    Holzer G; Riegler E; Hönigsmann H; Farokhnia S; Schmidt JB
    Br J Dermatol; 2005 Sep; 153(3):626-34. PubMed ID: 16120154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience with an injectionable estriol Depot preparation. (Gynaesan pro injectione)].
    Lauritzen C
    Munch Med Wochenschr; 1968 May; 110(19):1203-6. PubMed ID: 5695211
    [No Abstract]   [Full Text] [Related]  

  • 20. Estriol: safety and efficacy.
    Head KA
    Altern Med Rev; 1998 Apr; 3(2):101-13. PubMed ID: 9577246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.